Fischer-Tropsch catalyst production

Details for Australian Patent Application No. 2004231079 (hide)

Owner ExxonMobil Research and Engineeering Company

Inventors Malek, Andrzej M.; Marler, David O.; Trevino, Horacio M.; Leviness, Stephen C.; Bell, Weldon K.

Agent Watermark

Pub. Number AU-B-2004231079

PCT Pub. Number WO2004/091788

Priority 10/819,379 06.04.04 US; 60/462,016 11.04.03 US

Filing date 9 April 2004

Wipo publication date 28 October 2004

Acceptance publication date 11 June 2009

International Classifications

B01J 37/18 (2006.01) Processes, in general, for preparing catalysts

B01J 23/75 (2006.01) Catalysts comprising metals or metal oxides or hydroxides, not provided for in group - Cobalt

B01J 23/889 (2006.01) Catalysts comprising metals or metal oxides or hydroxides, not provided for in group

B01J 37/12 (2006.01) Processes, in general, for preparing catalysts

C10G 2/00 (2006.01) Production of liquid hydrocarbon mixtures of undefined composition from oxides of carbon

Event Publications

27 October 2005 PCT application entered the National Phase

  PCT publication WO2004/091788 Priority application(s): WO2004/091788

11 June 2009 Application Accepted

  Published as AU-B-2004231079

8 October 2009 Standard Patent Sealed

1 November 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004231080-Fischer-Tropsch catalyst production

2004231078-Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis